International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
IC-AIRCM-T3-2026
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 2
March-April 2026
Indexing Partners
The Cognitive Footprint of Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) in Chimeric Antigen Receptor T-Cell Therapy (CAR-T): A Systematic Review
| Author(s) | Ms. Purvi Jain, Ms. Amreen Kaur, Ms. Anjali Gupta |
|---|---|
| Country | India |
| Abstract | Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) presents a significant side-effect of CAR-T cell therapy, with cognitive dysfunction emerging as a core manifestation that can impact patient quality of life and their functional outcomes.To systematically review current evidence on the clinical impact, underlying mechanisms, assessment methodologies, and management strategies of ICANS-related cognitive dysfunction in CAR-T recipients.A systematic literature search was conducted across PubMed, EMBASE, Google Scholar and Web of Science databases following PRISMA guidelines. Studies reported ICANS affects 26.9% of CAR-T recipients overall, with cognitive dysfunction representing the most prevalent manifestation. Deficits in attention, memory, executive function, and language processing were consistently reported, with varying degrees of persistence ranging from days to months post-treatment.ICANS-related cognitive dysfunction represents a significant clinical concern requiring standardized assessment protocols and targeted interventions. Further research is needed to establish predictive biomarkers and effective management strategies. |
| Keywords | ICANS, Cognition, CAR-T Therapy, Oncology, Psych-oncology |
| Field | Medical / Pharmacy |
| Published In | Volume 7, Issue 5, September-October 2025 |
| Published On | 2025-10-26 |
| DOI | https://doi.org/10.36948/ijfmr.2025.v07i05.56013 |
Share this

E-ISSN 2582-2160
CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals